Developing More Clinically Safe & Efficacious Therapeutics for GI Inflammatory Diseases The GI Inflammatory Diseases Summit (GIIDS) focuses exclusively on overcoming translational drug development challenges to achieve more clinically safe […]

Returning to Boston for its 2nd successful year in 2019, the CPLM Summit features a fresh speaker line-up including the FDA, Alnylam, kaleo, Novartis and many others, as well as […]

The Cell Engager Summit is the only meeting focused on developing multi-specific cell engaging therapies in liquid and solid tumor indications; accelerating early discovery innovation into the clinic. Overcome safety and […]